Showing results (51-60 of 191) with videos related to
Sort By:
Pageof 20
Placenta|July 18, 2006
The mitotic manipulation of cytotrophoblast differentiation in vitroI P Crocker, P Arthur, A E Heazell, et al.Obstetrics and Gynecology|November 1, 1995
Elevated serum levels of vascular endothelial growth factor in patients with preeclampsiaP N Baker, J Krasnow, J M Roberts, et al.British Journal of Obstetrics and Gynaecology|August 24, 1999
Neutrophil function in women with pre-eclampsiaI P Crocker, R P Wellings, J Fletcher, et al.Placenta|May 15, 2003
Vascular endothelial growth factor is a chemoattractant for trophoblast cellsG E Lash, A Y Warren, S Underwood, et al.Hypertension (Dallas, Tex. : 1979)|January 1, 1996
Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclinP N Baker, S T Davidge, J Barankiewicz, et al.Journal of Hypertension|May 29, 2000
Polymorphism in oestrogen response element associated with variation in plasma angiotensinogen concentrations in healthy pregnant womenL Morgan, S Crawshaw, P N Baker, et al.American Journal of Obstetrics and Gynecology|January 29, 2000
The effects of vascular endothelial growth factor on endothelial cells: a potential role in preeclampsiaJ C Brockelsby, F W Anthony, I R Johnson, et al.Clinical Orthopaedics and Related Research|September 5, 2009
THA with the ABG I prosthesis at 15 years. Excellent survival with minimal osteolysisP N Baker, I A McMurtry, G Chuter, et al.Histochemistry and Cell Biology|September 6, 2005
E-cadherin in the assessment of aberrant placental cytotrophoblast turnover in pregnancies complicated by pre-eclampsiaL M Brown, H A Lacey, P N Baker, et al.BJOG : an International Journal of Obstetrics and Gynaecology|December 17, 2008
An overview of proteomic and metabolomic technologies and their application to pregnancy researchR P Horgan, O H Clancy, J E Myers, et al.Pageof 20